Azilsartan Kamedoxomil

Overview

Azilsartan Kamedoxomil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103795).

API suppliers (14)

Suppliers of Azilsartan Kamedoxomil backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• Piramal Pharma LimitedIndia1 active DMF
• MSN Laboratories Private LimitedIndia1 active DMF
• Jiangxi Dongfeng Pharmaceutical Co., LtdChina1 active DMF
• Alkem Laboratories LimitedIndia1 active DMF
• CHROMO LABORATORIES INDIA PRIVATE LTDIndia1 active DMF
• WUHAN CALMLAND PHARMACEUTICALS CO LTDChina1 active DMF
• ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO LTDChina1 active DMF
• LINHAI TIANYU PHARMACEUTICAL CO LTDChina1 active DMF
• XUZHOU WANBANG JINQIAO PHARMA CO LTDChina1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• JUBILANT BIOSYS LTDIndia1 active DMF
• HONOUR LAB LTDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Azilsartan Kamedoxomil expires 26 Mar 2028 and exclusivity 12 Dec 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

potassium 3-[2-[4-[[2-ethoxy-7-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]benzimidazol-1-yl]methyl]phenyl]phenyl]-1,2,4-oxadiazol-5-olate

Canonical SMILES

CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=N5)[O-])C(=O)OCC6=C(OC(=O)O6)C.[K+]

InChIKey

IHWFKDWIUSZLCJ-UHFFFAOYSA-M